Kai Qu, Yuan Zhong, Li Zhu, Nianlian Mou, Yu Cao, Jie Liu, Shuai Wu, Meng Yan, Fei Yan, Jiawei Li, Cheng Zhang, Guicheng Wu, Kun Zhang, Xian Qin, Wei Wu
Atherosclerosis (AS) management typically relies on therapeutic drug interventions, but these strategies typically have drawbacks, including poor site specificity, high systemic intake, and undesired side effects. The field of cell membrane camouflaged biomimetic nanomedicine offers the potential to address these challenges thanks to its ability to mimic the natural properties of cell membranes that enable enhanced biocompatibility, prolonged blood circulation, targeted drug delivery, and evasion of immune recognition, ultimately leading to improved therapeutic outcomes and reduced side effects...
April 30, 2024: Advanced Healthcare Materials